DE69106543D1 - Verwendung von Buspiron in Schlaf-Apnoe. - Google Patents

Verwendung von Buspiron in Schlaf-Apnoe.

Info

Publication number
DE69106543D1
DE69106543D1 DE69106543T DE69106543T DE69106543D1 DE 69106543 D1 DE69106543 D1 DE 69106543D1 DE 69106543 T DE69106543 T DE 69106543T DE 69106543 T DE69106543 T DE 69106543T DE 69106543 D1 DE69106543 D1 DE 69106543D1
Authority
DE
Germany
Prior art keywords
buspirone
sleep apnea
useful
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106543T
Other languages
English (en)
Other versions
DE69106543T2 (de
Inventor
William C Dement
Mark R Rosekind
Jeffrey L Schwimmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Leland Stanford Junior University
Original Assignee
Bristol Myers Squibb Co
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Leland Stanford Junior University filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69106543D1 publication Critical patent/DE69106543D1/de
Publication of DE69106543T2 publication Critical patent/DE69106543T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69106543T 1990-02-12 1991-02-11 Verwendung von Buspiron in Schlaf-Apnoe. Expired - Fee Related DE69106543T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47980390A 1990-02-12 1990-02-12

Publications (2)

Publication Number Publication Date
DE69106543D1 true DE69106543D1 (de) 1995-02-23
DE69106543T2 DE69106543T2 (de) 1995-05-11

Family

ID=23905511

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106543T Expired - Fee Related DE69106543T2 (de) 1990-02-12 1991-02-11 Verwendung von Buspiron in Schlaf-Apnoe.

Country Status (12)

Country Link
EP (1) EP0442423B1 (de)
JP (1) JP3168543B2 (de)
KR (1) KR910015300A (de)
AT (1) ATE116854T1 (de)
CA (1) CA2036055A1 (de)
DE (1) DE69106543T2 (de)
DK (1) DK0442423T3 (de)
ES (1) ES2069758T3 (de)
GR (1) GR3015716T3 (de)
HK (1) HK1005016A1 (de)
HU (1) HUT56496A (de)
IL (1) IL97054A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
ES2267253T3 (es) * 1998-02-27 2007-03-01 The Board Of Trustees Of The University Of Illinois Agentes con actividad relacionada con la serotonina para el tratamiento de la apnea del sueño.
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
EP1833467B1 (de) 2004-12-20 2016-08-03 Collegium Pharmaceutical, Inc. Pharmazeutische zusammensetzungen gegen schlafstörungen
MX2008000250A (es) 2005-07-06 2008-03-19 Sepracor Inc Combinaciones de eszopiclona y trans-4-(3,4-diclorofenil)-1,2,3,4- tetrahidro-n-metil-1-naftalenamina o trans 4-(3,4-diclorofenil)-1, 2,3,4-tetrahidro-1-naftalenamina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y
CA2648121C (en) 2006-03-31 2013-08-06 Sepracor Inc. Preparation of chiral amides and amines
EP2429514A1 (de) * 2009-05-13 2012-03-21 Sunovion Pharmaceuticals Inc. Zusammensetzungen mit transnorsertralin- und serotoninrezeptor-1a-agonisten/antagonisten und ihre verwendung

Also Published As

Publication number Publication date
IL97054A0 (en) 1992-03-29
HU910436D0 (en) 1991-08-28
EP0442423A1 (de) 1991-08-21
ATE116854T1 (de) 1995-01-15
HUT56496A (en) 1991-09-30
JP3168543B2 (ja) 2001-05-21
HK1005016A1 (en) 1998-12-18
EP0442423B1 (de) 1995-01-11
DE69106543T2 (de) 1995-05-11
GR3015716T3 (en) 1995-07-31
KR910015300A (ko) 1991-09-30
ES2069758T3 (es) 1995-05-16
JPH0826997A (ja) 1996-01-30
DK0442423T3 (da) 1995-03-20
CA2036055A1 (en) 1991-08-13
IL97054A (en) 1995-10-31

Similar Documents

Publication Publication Date Title
FI913142A (fi) Migraenfoerhindrande alkoxipyrimidinderivat.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
DE69212620D1 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
ATE116854T1 (de) Verwendung von buspiron in schlaf-apnoe.
DE69230654D1 (de) Commiphora-Mukul-Extrakte und deren therapeutische Verwendung
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
DE3876846D1 (de) Morpholinderivate und deren verwendung.
DE69327813D1 (de) Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung
DE59108809D1 (de) 3-(Cis-3-Hexenyloxy)-propan-nitrile, dessen Herstellung und dessen Verwendung
ATE137955T1 (de) Verwendung von 1,2-dipalmitoyl-l-alpha- phosphatidyl-n,n-dimethylethanilamine in dermatologischen und kosmetischen zusammensetzungen
ATE114464T1 (de) Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
DE59207086D1 (de) Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
SE9403861D0 (sv) Novel medicinal use
NO913237D0 (no) Fremgangsmaate og innretning for fremstilling av hoey ren 1,2-dikloretan med samtidig varmegjenvinning.
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
KR910016422U (ko) 환자 및 일반인 겸용 온열침구
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
KR940014599U (ko) 수면시 코골기 및 이갈이 방지구
ATE83662T1 (de) Morpholinderivate und deren verwendung.
GB9319940D0 (en) Variable impedance in the treatment of sleep apnea

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee